Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2M Sell
35,000
-5,000
-13% -$284K 0.96% 31
2025
Q4
$2.13M Hold
40,000
0.76% 33
2025
Q3
$2M Hold
40,000
0.73% 35
2025
Q2
$2.06M Hold
40,000
0.82% 35
2025
Q1
$2.14M Hold
40,000
1.1% 26
2024
Q4
$1.91M Hold
40,000
0.78% 33
2024
Q3
$1.78M Hold
40,000
0.77% 35
2024
Q2
$1.7M Hold
40,000
0.7% 36
2024
Q1
$1.66M Hold
40,000
0.73% 40
2023
Q4
$1.47M Hold
40,000
0.81% 34
2023
Q3
$1.42M Hold
40,000
0.94% 32
2023
Q2
$1.36M Hold
40,000
0.89% 36
2023
Q1
$1.38M Hold
40,000
1.18% 33
2022
Q4
$1.31M Hold
40,000
1.24% 28
2022
Q3
$1.2M Hold
40,000
1.37% 25
2022
Q2
$1.17M Hold
40,000
1.15% 29
2022
Q1
$1.33M Buy
+40,000
New +$1.29M 0.82% 36
2021
Q4
Sell
-40,000
Closed -$1.14M 105
2021
Q3
$1.14M Buy
+40,000
New +$1.13M 0.54% 44

Other funds holding MPLX

Geneva Partners's MPLX Position: Q1 2026 in Review

Geneva Partners reduced its MPLX (MPLX) stake by 13% in Q1 2026, selling an estimated $284K and leaving 35,000 shares worth $2M. The position accounts for 0.96% of the portfolio, ranked #31.

Geneva Partners first reported a position in MPLX in Q3 2021 and has held it in 18 quarters since. The position peaked at $2.14M in Q1 2025. 644 funds tracked by Wall St. Rank hold MPLX as of Q1 2026.

  • Geneva Partners held 35,000 shares of MPLX worth $2M as of Q1 2026.
  • Geneva Partners sold 5,000 MPLX shares in Q1 2026, an estimated $284K.
  • MPLX made up 0.96% of Geneva Partners's portfolio in Q1 2026, its #31 holding.
  • Geneva Partners first reported a position in MPLX in Q3 2021 and has held it in 18 quarters since.
  • Geneva Partners's MPLX position peaked at $2.14M in Q1 2025.
  • 644 funds tracked by Wall St. Rank held MPLX as of Q1 2026.

Based on Geneva Partners's 13F filing for Q1 2026, filed 29 Apr 2026.